Permanent Pacing Indications
Definition
Permanent cardiac pacing (PPM implantation) is indicated to alleviate symptoms of cerebral hypoperfusion attributable to bradycardia, or to prevent sudden syncope/death from predictable complete AV block, once reversible/physiologic causes have been excluded. Symptomatic SND is the most common indication, followed closely by AV block. The fundamental difference: SND pacing requires symptom–bradycardia correlation; certain forms of infranodal AV block warrant pacing regardless of symptoms.
Key Concepts
Sinus Node Dysfunction (SND)
| COR |
LOE |
Indication |
| I |
C-LD |
Symptoms directly attributable to SND |
| I |
C-EO |
Symptomatic sinus bradycardia from essential GDMT with no alternative treatment |
| IIa |
C-EO |
Tachy-brady syndrome with symptoms attributable to bradycardia |
| IIa |
C-EO |
Symptomatic chronotropic incompetence with rate-responsive programming |
| IIb |
C-LD |
Trial of oral theophylline to predict pacing response |
- No minimum HR or pause duration for PPM in SND — symptom–bradycardia correlation is the key determinant (sources/bradycardia-acc-aha-hrs-2018, very high)
- Nocturnal bradycardia alone is NOT an indication for PPM; should prompt sleep apnea screening
- Primary benefit of PPM in SND: QOL improvement (not mortality benefit)
Acquired Atrioventricular Block (Regardless of Symptoms)
| COR |
LOE |
Indication |
| I |
B-NR |
Acquired Mobitz type II AV block not from reversible/physiologic causes |
| I |
B-NR |
Acquired high-grade (≥2 consecutive non-conducted P waves) AV block not from reversible/physiologic causes |
| I |
B-NR |
Acquired third-degree (complete) AV block not from reversible/physiologic causes |
- These indications apply regardless of symptoms because infranodal block can progress suddenly to complete AV block with slow/absent ventricular escape → syncope and death (sources/bradycardia-acc-aha-hrs-2018, very high)
- Natural history studies (1970s–80s): untreated Mobitz II/third-degree AV block → recurrent syncope, HF, and excess mortality; pacing improves survival
- High-grade AV block: even asymptomatic patients had poor prognosis if untreated
Acquired AV Block — Symptom-Dependent Indications
| COR |
LOE |
Indication |
| I |
C-LD |
Permanent AF + symptomatic bradycardia |
| I |
C-LD |
Symptomatic AV block from essential GDMT with no alternative treatment |
| IIa |
C-LD |
Marked first-degree or Wenckebach AV block with symptoms clearly attributable to AV block |
Special Disease-Specific Pacing Indications
| COR |
LOE |
Indication |
| I |
B-NR |
Neuromuscular diseases (myotonic dystrophy type 1, Kearns-Sayre syndrome) + second-degree, third-degree AV block, or HV ≥70 ms — regardless of symptoms (± ICD if >1 year survival expected) |
| IIa |
B-NR |
Infiltrative cardiomyopathy (cardiac sarcoidosis, amyloidosis) + Mobitz II/high-grade/third-degree AV block (± ICD if >1 year survival expected) |
| IIa |
B-NR |
Lamin A/C mutations (limb-girdle, Emery-Dreifuss muscular dystrophies) + PR >240 ms AND LBBB (± ICD) |
| IIb |
C-LD |
Myotonic dystrophy type 1 + PR >240 ms, QRS >120 ms, or fascicular block (± ICD) |
- Myotonic dystrophy type 1: up to 20% have AV block on routine ECG; >50% with normal ECG may have infra-Hisian block at EPS; HV ≥70 ms → 47% risk of high-grade AV block; 75% lower SCD risk with pacemaker (sources/bradycardia-acc-aha-hrs-2018, very high)
- Kearns-Sayre syndrome: progressive conduction disease; pacing reasonable regardless of symptoms given risk of sudden complete AV block
Conduction Disorders with 1:1 AV Conduction
| COR |
LOE |
Indication |
| I |
C-LD |
Syncope + BBB + HV ≥70 ms or infranodal block at EPS |
| I |
C-LD |
Alternating bundle branch block (alternating LBBB and RBBB) |
| IIa |
C-LD |
Kearns-Sayre syndrome + conduction disorders (± ICD) |
| IIb |
C-LD |
Anderson-Fabry disease + QRS >110 ms (± ICD) |
| IIb |
C-LD |
HF + LVEF 36–50% + LBBB (QRS ≥150 ms): CRT may be considered |
| III Harm |
B-NR |
Asymptomatic isolated conduction disease with 1:1 AV conduction (no other indication) |
- Alternating bundle branch block implies bilateral bundle disease — high risk of sudden complete AV block; all patients should receive PPM (sources/bradycardia-acc-aha-hrs-2018, very high)
- Bundle branch block with syncope: EPS identifies infranodal disease (HV ≥70 ms or frank block) → PPM
Special Population: TAVR
| COR |
LOE |
Indication |
| I |
B-NR |
New persistent AV block with symptoms/hemodynamic instability after TAVR → PPM before discharge |
| IIa |
B-NR |
New persistent BBB after TAVR → careful surveillance for bradycardia |
| IIb |
B-NR |
New persistent LBBB after TAVR → PPM may be considered |
- New LBBB 19–55%; new high-degree AV block ~10% after TAVR; many resolve before discharge
- Early PPM for new LBBB is NOT protective against increased mortality associated with new LBBB (sources/bradycardia-acc-aha-hrs-2018, very high)
Special Population: Acute MI
| COR |
LOE |
Indication |
| I |
B-NR |
Temporary pacing for refractory symptomatic/hemodynamically significant bradycardia in AMI |
| I |
B-NR |
Waiting period before PPM decision in AMI |
| I |
B-NR |
PPM (after waiting) for persistent or infranodal Mobitz II/high-grade AV block/alternating BBB/third-degree AV block in AMI |
| IIa |
B-NR |
Atropine for symptomatic SND or AV nodal block in AMI |
| III Harm |
B-NR |
PPM for transient AV block that resolves in AMI |
| III Harm |
B-NR |
PPM for new BBB or isolated fascicular block without second/third-degree AV block in AMI |
- Inferior MI: AV block often transient (vagal/AV nodal ischemia) — await resolution before PPM
- Anterior MI + AV block: reflects extensive myocardial damage; prognosis determined by infarct extent, not AV block itself
Pacing Mode Selection
- SND: Atrial-based (DDD/AAI) over VVI (reduces new AF); minimize ventricular pacing in DDD
- AV block (any EF): Dual chamber preferred over VVI
- LVEF 36–50% + ventricular pacing >40% expected: CRT or His bundle pacing preferred over RV pacing (Class IIa, B-R [SR]) — prevents pacing-induced cardiomyopathy
- LVEF 36–50% + ventricular pacing <40% expected: RV pacing reasonable (Class IIa)
- LVEF ≤35% + ventricular pacing anticipated >40%: CRT (per 2013 ACCF/AHA HF guideline — outside scope of this guideline, but referenced)
- AV node level block: His bundle pacing may be considered (Class IIb)
- Permanent/persistent AF without rhythm control: No atrial lead (Class III Harm)
Shared Decision-Making and End-of-Life
- Shared decision-making endorsed; patient-centered care emphasized
- Patients with decision-making capacity have the right to refuse or withdraw pacemaker therapy, even if pacemaker-dependent → considered palliative/end-of-life care, NOT physician-assisted suicide (sources/bradycardia-acc-aha-hrs-2018, very high)
- All decisions are patient-specific and complex, should involve all stakeholders
Contradictions / Open Questions
- Optimal physiologic pacing modality (CRT vs His bundle pacing vs LBBAP) for LVEF 36–50% not established — 2018 guideline predates CSP trials; see concepts/Conduction-System-Pacing for more recent evidence
- No RCTs for pacing in tachy-brady syndrome specifically
- Timing of PPM after TAVR not standardized; no prospective RCTs
- Rate-responsive pacing benefit in SND: one RCT showed no benefit (confounded by high RV pacing percentage); question remains whether modern devices with lower RV pacing would show different results
- Evidence base for many SND pacing recommendations is C-level (expert opinion or limited data); mortality benefit not demonstrated
Connections
Sources